Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins.

In response to insulin, tyrosine kinase activity of the insulin receptor is stimulated, leading to autophosphorylation and tyrosine phosphorylation of proteins including insulin receptor subunit (IRS)-1, IRS-2, and Shc. Phosphorylation of these proteins leads to activation of downstream events that mediate insulin action. Insulin receptor kinase activity is requisite for the biological effects of insulin, and understanding regulation of insulin receptor phosphorylation and kinase activity is essential to understanding insulin action. Receptor tyrosine kinase activity may be altered by direct changes in tyrosine kinase activity, itself, or by dephosphorylation of the insulin receptor by protein-tyrosine phosphatases. After 1 min of insulin stimulation, the insulin receptor was tyrosine phosphorylated 8-fold more and Shc was phosphorylated 50% less in 32D cells containing both IRS-1 and insulin receptors (32D/IR+IRS-1) than in 32D cells containing only insulin receptors (32D/IR), insulin receptors and IRS-2 (32D/IR+IRS-2), or insulin receptors and a form of IRS-1 that cannot be phosphorylated on tyrosine residues (32D/IR+IRS-1F18). Therefore, IRS-1 and IRS-2 appeared to have different effects on insulin receptor phosphorylation and downstream signaling. Preincubation of cells with pervanadate greatly decreased protein-tyrosine phosphatase activity in all four cell lines. After pervanadate treatment, tyrosine phosphorylation of insulin receptors in insulin-treated 32D/IR, 32D/ IR+IRS-2, and 32D/IR+IRS-1F18 cells was markedly increased, but pervanadate had no effect on insulin receptor phosphorylation in 32D/IR+IRS-1 cells. The presence of tyrosine-phosphorylated IRS-1 appears to increase insulin receptor tyrosine phosphorylation and potentially tyrosine kinase activity via inhibition of protein-tyrosine phosphatase(s). This effect of IRS-1 on insulin receptor phosphorylation is unique to IRS-1, as IRS-2 had no effect on insulin receptor tyrosine phosphorylation. Therefore, IRS-1 and IRS-2 appear to function differently in their effects on signaling downstream of the insulin receptor. IRS-1 may play a major role in regulating insulin receptor phosphorylation and enhancing downstream signaling after insulin stimulation.

[1]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[2]  M. Kasuga,et al.  Roles of the Complex Formation of SHPS-1 with SHP-2 in Insulin-stimulated Mitogen-activated Protein Kinase Activation* , 1998, The Journal of Biological Chemistry.

[3]  G. Shulman,et al.  Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis. , 1998, Diabetes.

[4]  E. Van Obberghen,et al.  Tyr624 and Tyr628 in Insulin Receptor Substrate-2 Mediate Its Association with the Insulin Receptor* , 1997, The Journal of Biological Chemistry.

[5]  D. Alexander,et al.  The role of phosphotyrosine phosphatases in haematopoietic cell signal transduction , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[6]  A. Ullrich,et al.  The transmembrane protein tyrosine phosphatase α dephosphorylates the insulin receptor in intact cells , 1997, FEBS letters.

[7]  M. Gresser,et al.  Mechanism of Inhibition of Protein-tyrosine Phosphatases by Vanadate and Pervanadate* , 1997, The Journal of Biological Chemistry.

[8]  B. Goldstein,et al.  Functional Association between the Insulin Receptor and the Transmembrane Protein-tyrosine Phosphatase LAR in Intact Cells* , 1997, The Journal of Biological Chemistry.

[9]  M. White,et al.  Insulin-induced egr-1 and c-fos Expression in 32D Cells Requires Insulin Receptor, Shc, and Mitogen-activated Protein Kinase, but Not Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase Activation* , 1996, The Journal of Biological Chemistry.

[10]  J. Dixon,et al.  Form and Function in Protein Dephosphorylation , 1996, Cell.

[11]  Lynne Yenush,et al.  The Pleckstrin Homology Domain Is the Principle Link between the Insulin Receptor and IRS-1* , 1996, The Journal of Biological Chemistry.

[12]  L. Velloso,et al.  Insulin Induces Tyrosine Phosphorylation of JAK2 in Insulin-sensitive Tissues of the Intact Rat* , 1996, The Journal of Biological Chemistry.

[13]  Z. Zhao,et al.  Activation of Mitogen-activated Protein (MAP) Kinase Pathway by Pervanadate, a Potent Inhibitor of Tyrosine Phosphatases* , 1996, The Journal of Biological Chemistry.

[14]  T. Imamura,et al.  Functional Importance of Amino-terminal Domain of Shc for Interaction with Insulin and Epidermal Growth Factor Receptors in Phosphorylation-independent Manner* , 1996, The Journal of Biological Chemistry.

[15]  J. Blenis,et al.  YMXM motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites , 1996, Molecular and cellular biology.

[16]  M. Bernier,et al.  A Peptide-based Protein-tyrosine Phosphatase Inhibitor Specifically Enhances Insulin Receptor Function in Intact Cells* , 1996, The Journal of Biological Chemistry.

[17]  O. Pedersen,et al.  A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. , 1996, The Journal of clinical investigation.

[18]  M. White,et al.  Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase , 1996, Molecular and cellular biology.

[19]  C. Kahn,et al.  Molecular scanning of the insulin receptor substrate.1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms , 1996 .

[20]  B. Goldstein,et al.  Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR. , 1996, Molecular endocrinology.

[21]  E. Van Obberghen,et al.  Insulin Receptor Substrate-2 Binds to the Insulin Receptor through Its Phosphotyrosine-binding Domain and through a Newly Identified Domain Comprising Amino Acids 591786 (*) , 1996, The Journal of Biological Chemistry.

[22]  R. Mooney,et al.  The Transmembrane Protein-tyrosine Phosphatase CD45 Is Associated with Decreased Insulin Receptor Signaling (*) , 1996, The Journal of Biological Chemistry.

[23]  卯木 智.  Src homology 2 domains of protein tyrosine phosphatase are associated in vitro with both the insulin receptor and insulin receptor substrate-1 via different phosphotyrosine motifs , 1996 .

[24]  E. Van Obberghen,et al.  Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786. , 1996, The Journal of biological chemistry.

[25]  M. Czech,et al.  Insulin Regulation of Membrane-associated Insulin Receptor Substrate 1 (*) , 1995, The Journal of Biological Chemistry.

[26]  T. Gustafson,et al.  Distinct Modes of Interaction of SHC and Insulin Receptor Substrate-1 with the Insulin Receptor NPEY Region via Non-SH2 Domains (*) , 1995, The Journal of Biological Chemistry.

[27]  J. Meyerovitch,et al.  Osmotic Loading of Neutralizing Antibodies Demonstrates a Role for Protein-tyrosine Phosphatase 1B in Negative Regulation of the Insulin Action Pathway (*) , 1995, The Journal of Biological Chemistry.

[28]  D. Accili,et al.  Tyrosine Phosphorylation of Insulin Receptor Substrate-1 in Vivo Depends upon the Presence of Its Pleckstrin Homology Region (*) , 1995, The Journal of Biological Chemistry.

[29]  P. Wilden,et al.  Combination of insulinomimetic agents H2O2 and vanadate enhances insulin receptor mediated tyrosine phosphorylation of IRS‐1 leading to IRS‐1 association with the phosphatidylinositol 3‐kinase , 1995, Journal of cellular biochemistry.

[30]  A. Craparo,et al.  Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain , 1995, Molecular and cellular biology.

[31]  C. Kahn,et al.  Insulin action and the insulin signaling network. , 1995, Endocrine reviews.

[32]  G. Siemeister,et al.  Recombinant Human Insulin Receptor Substrate-1 Protein , 1995, The Journal of Biological Chemistry.

[33]  B. Goldstein,et al.  Insulin Receptor Signaling Is Augmented by Antisense Inhibition of the Protein Tyrosine Phosphatase LAR (*) , 1995, The Journal of Biological Chemistry.

[34]  A. Saltiel,et al.  Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Olefsky,et al.  Insulin Stimulates the Tyrosine Dephosphorylation of pp125 Focal Adhesion Kinase (*) , 1995, The Journal of Biological Chemistry.

[36]  D. Accili,et al.  Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. , 1994, The Journal of clinical endocrinology and metabolism.

[37]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[38]  T. Yagi,et al.  Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 , 1994, Nature.

[39]  T. O’Neill,et al.  Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system , 1994, Molecular and cellular biology.

[40]  S. Shoelson,et al.  Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. , 1994, The Journal of biological chemistry.

[41]  A. Saltiel,et al.  Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. , 1994, The Journal of biological chemistry.

[42]  N. Ruderman,et al.  The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. , 1994, The Journal of biological chemistry.

[43]  G. Lienhard,et al.  Dephosphorylation of insulin receptor substrate 1 by the tyrosine phosphatase PTP2C. , 1994, The Journal of biological chemistry.

[44]  J. Olefsky,et al.  Src homology 2 domains of protein tyrosine phosphatase are associated in vitro with both the insulin receptor and insulin receptor substrate‐1 via different phosphotyrosine motifs , 1994, FEBS letters.

[45]  A. Ullrich,et al.  Differential activities of protein tyrosine phosphatases in intact cells. , 1993, The Journal of biological chemistry.

[46]  T. Hansen,et al.  Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus , 1993, The Lancet.

[47]  M. White,et al.  IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. , 1993, Science.

[48]  H. Maegawa,et al.  Src homology 2 domains of protein tyrosine phosphatase are phosphorylated by insulin receptor kinase and bind to the COOH-terminus of insulin receptors in vitro. , 1993, Biochemical and biophysical research communications.

[49]  M. White,et al.  The New Elements of Insulin Signaling: Insulin Receptor Substrate-1 and Proteins With SH2 Domains , 1993, Diabetes.

[50]  A. Ullrich,et al.  Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. , 1993, Science.

[51]  M. White,et al.  IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Kahn,et al.  Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function. , 1992, The Journal of biological chemistry.

[53]  C. Kahn,et al.  The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities. Analysis with insulin and anti-receptor antibodies. , 1992, The Journal of biological chemistry.

[54]  D. Brautigan,et al.  Activation of membrane protein-tyrosine phosphatase involving cAMP- and Ca2+/phospholipid-dependent protein kinases. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[55]  N. Tonks,et al.  Purification of protein-tyrosine phosphatases from human placenta. , 1991, Methods in enzymology.

[56]  L. Jarett,et al.  Partial Characterization of Mechanism of Insulin Accumulation in H35 Hepatoma Cell Nuclei , 1990, Diabetes.

[57]  C. Kahn,et al.  The insulin receptor with phenylalanine replacing tyrosine-1146 provides evidence for separate signals regulating cellular metabolism and growth. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[58]  W. Merlevede,et al.  Isolation and characterization of a tyrosyl phosphatase activator from rabbit skeletal muscle and Xenopus laevis oocytes. , 1990, Biochemistry.

[59]  C. Kahn,et al.  The Insulin Receptor Tyrosine Kinase , 1990 .

[60]  Kahn Cr,et al.  Separate domains of the insulin receptor contain sites of autophosphorylation and tyrosine kinase activity , 1987 .

[61]  C. Kahn,et al.  Separate domains of the insulin receptor contain sites of autophosphorylation and tyrosine kinase activity. , 1987, Biochemistry.

[62]  W. Rutter,et al.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose , 1986, Cell.